{
  "ticker": "IPD",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969733",
  "id": "02969733",
  "pages": 3,
  "price_sensitive": true,
  "date": "20250716",
  "time": "0945",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250716/pdf/06lv6xr009kg3p.pdf",
  "summary": "### **Material Information Summary**  \n\n#### **Sales Update**  \n- **Q4 FY25 US unit sales**: 44 units (+100% QoQ, +91% YoY).  \n- **Record Total Contract Value (TCV)**: A$6.3m (+29% QoQ).  \n- **Key client win**: 9-unit contract with **Legacy Health** (major US healthcare system).  \n\n#### **Capital Growth Facility Update**  \n- **Tranche 2 drawdown**: US$5m exercised under **SWK Funding LLC facility** (total facility: US$15m).  \n- **Extended interest-only period**: Increased from 24 to 36 months.  \n\n#### **Forward-Looking Guidance**  \n- Targeting similar Q1 FY26 sales, with further growth expected as pipeline matures.  \n- **Next update**: Q4 FY25 Quarterly Report + 4C on **31 July 2025** (investor call to follow).  \n\n**No material information omitted.**",
  "usage": {
    "prompt_tokens": 2221,
    "completion_tokens": 211,
    "total_tokens": 2432,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-15T23:51:09.922871"
}